Dr Michael Gantier
ARC Future Fellow
Centre for Innate Immunity and Infectious Diseases
The central aim of Dr Michael Gantier’s research is to define how nucleic acids modulate immune responses, in both homeostatic conditions and following infection. After joining Professor Bryan Williams’ laboratory in 2006, Dr
Gantier set out to investigate how endogenous and foreign nucleic acids controlled innate immune responses. Building on technical expertise on small RNAs acquired during his PhD (University College Dublin, Ireland), he
established this research theme in the Williams laboratory, and more broadly in Australia.
In 2015, following the award of an ARC Future Fellowship and several NHMRC project grants, he was promoted to lead his own research group in the Hudson Institute of Medical Research. The group’s research has important implications for our basic understanding of inflammation and the translational use of nucleic acids therapeutics in the clinic.
Amongst his scientific achievements are publications in the highest-ranking science and medical research journals, including Nature Immunology, Cell Host Microbe, Nucleic Acids Research, PNAS, Journal of Virology, Journal of Immunology, among others.